retatrutide phase 2 trial type 2 diabetes results 2024 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new 3 shows. is part of an emerging generation New clinical trial results show

Melanotan 2 activates additional receptors beyond MC1R, resulting in broader systemic responses, such as nausea, appetite suppression, or flushing seen in research environments

The gut microbiome can affect the development and progression of atherosclerosis and CHD in various ways

Dubois, V., Eeckhoute, J., Lefebvre, P

In April 2026, CMS announced it would not move forward with the Part D portion of BALANCE in 2027, citing the need for more data and a smoother transition

Many patients also experience improved mobility, fewer aches and pains, better mood, and increased motivation to maintain healthy eating and exercise habits